Binding of granulocyte colony-stimulating factor (G-CSF) t o normal myeloid cells activates the protein tyrosine kinases Lyn and Syk and results in the immediate early upregulation of G-CSF receptor (R) mRNA. In our studies of the signaling pathways activated by G-CSF that are coupled t o proliferation and differentiation of myeloid cells, we examined whether G-CSF activated a latent transcription factor belonging to the STAT protein family. Electrophoretic mobility shift assays (EMSAs) of nuclear extracts from G-CSF-stimulated human myeloid cells showed the rapid activation of a DNA-binding protein that bound to the high-affinity seruminducible element (hSIE) and migrated with mobility similar t o serum inducible factor (SIFI-A (Stat3 homodimer). The G-CSF-stimulated SIF-A complex (G-SIF-A) did not bind t o duplex oligonucleotides used t o purify and characterize RANULOCYTE colony-stimulating factor (G-CSF) is the cytokine that is critical for driving normal neutrophil production and mat~ration."~ The receptor for G-CSF (G-CSFR) is a member of the hematopoietidcytokine receptor family?.' Structure-function studies have shown that, although only the proximal half of the G-CSFR cytosolic domain is required for optimal proliferation,6' the complete cytosolic domain is essential for signaling differentiation."' The signaling proteins specific for differentiation that are activated by the distal half of the cytosolic domain of the G-CSFR are unknown.
We have recently shown that three proteins (pp50, pp70, and pp80) are tyrosine-phosphorylated in response to G-C S F and that pp50 and pp70 are the protein tyrosine kinases Lyn and Syk, respectively." The identity of pp80 is unknown. In addition, we showed immediate early upregulation of G-CSFR mRNA by G-CSF in murine bone marrow cells and the G-CSF-responsive murine cell line, 32Dc13, that proliferates and differentiates into neutrophilic granulocytes in the presence of G-CSF.'." Recently, proteins of the signal transducers and activators of transcription (STAT) family have been shown to be activated by several members of the hematopoietidcytokine receptor STAT proteins characterized thus far range in size, from 77 to l13 kD. These proteins are latent transcription factors that become activated by tyrosine phosphorylation on ligand binding and translocate from the cytoplasm to the nucleus. In the nucleus, each protein binds to a characteristic enhancer sequence and activates gene transcription.
G-CSF has been shown to activate Stat3 (molecular weight [M,] of 92,000) in the human myeloid leukemia cell line, AML-193.2' STAT protein activation in normal myeloid cells has not yet been described. We show in this report that G-CSF activates in normal human myeloid cells a distinct high-affinity serum-inducible element (hS1E)-binding factor G-SIF-A with electrophoretic mobility and DNA binding properties similar to Stat3. Furthermore, we provide evidence that optimal activation of G-SIF-A maps to the region of the G-CSFR required for differentiation. other Stat proteins (Statl-6). In addition, antibodies raised against Statl-6 failed t o supershift the G-SIF-A complex or interfere with its formation. Based on its binding t o the hSlE and lack of antigenic cross-reactivity with other known STAT proteins that bind to this element, it is likely that G-SIF-A is composed of a distinct member of the STAT protein family. EMSAs of whole-cell extracts prepared from cell lines containing full-length and truncated mutants of the G-CSFR showed that activation of G-SIF-A did not correlate with proliferation; rather, optimal activation requires the distal half of the cytosolic domain of the G-CSFR that is essential for differentiation. Activation of G-SIF-A, therefore, may be an early G-CSFR-coupled event that is critical for myeloid maturation.
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MATERIALS AND METHODS

Cells.
Human polymorphonuclear neutrophils (PMN) were obtained from peripheral blood samples as describedz6; cells were 295% neutrophils by cytochemical staining. Bone marrow cells were obtained from aspirates of healthy volunteers or from vertebral bodies of organ donors, as describedz6 (M. Strong, Northwest Tissue Center, Seattle, WA, personal communication, March 9, 1995) . Bone marrow mononuclear cells (BMMC) were isolated on a Ficoll-Hypaque gradient and washed with phosphate-buffered saline (PBS). CD34' cells were isolated from BMMC using a Ceprate LC34 biotin-avidin column (CellPro Incorp, Bothell, WA) as described by the manufacturer. CD34' purity was 83% 2 3% as assessed by flow cytometry and the overall cell yield was 1% to 3%. The rat hepatoma cell line, H-35, and the human hepatoma cell line, HepG2, were grown as described?.*' BAF/B03 (B03) and BAFkIGR-26 (B-26) cells were maintained in RPMI-l640 medium supplemented with 10% fetal bovine serum (FBS) and 10% WEHI-3B-conditioned medium as a source of interleukin-3 (IL-3), as described? BAF/ HGR-57 (B-57), BAFkIGR-96 (B-96), and BAFkIGR-l83 (B-183; full-length receptor)" were maintained in RPMI-1640 supplemented with 10% FBS and 50 ng/mL recombinant human G-CSF (rhG-CSF; Neupogen). Before electrophoretic mobility shift assay (EMSA), all BAF-series cells were expanded in WMI-1640 containing 10% FBS and 10% WEHI-3B-conditioned medium. The murine G-CSF-responsive cell line, 32Dc13, was maintained in murine IL-3-containing medium, as described.' AML-193, a factor-dependent human acute myeloid leukemia cell line, was grown in granulocyte-macrophage colony-stimulating factor (GM-CSF), as described.'' AML-193 cells were shown to proliferate but not to differentiate in response to G-CSF.?' Reagents. rhG-CSF was obtained from Amgen (Thousand Oaks, CA) and rhGM-CSF was obtained from Immunex (Seattle, WA). rhlL-6 was the generous gift of Dr Steve Clark of the Genetics Institute (Cambridge, MA). Recombinant human interferon-y (IFNy ) was obtained from Genentech (South San Francisco, CA). Complimentary oligonucleotides were synthesized based on the published sequences with the addition of GATC at the 5' termini to allow radiolabeling, after annealing, by Klenow fill-in reaction using '?PdGTP and '*P-dATP. Sequences of oligonucleotides used in these studies are listed in Table I . Stat 1, Stat2, Stat3, Stat4, and Stat6 rabbit polyclonal antibody were obtained from Santa Cruz Biotechnology, Inc (Santa Cruz, CA). Statl polyclonal antibody was raised against the C-terminal end of human Stat 1, amino acids 7 16 to 739. Stat2 antisera was raised against the C-terminal end of human Stat2, amino acids 832 to 85 1. Stat3 antisera was raised against the Cterminal end of murine Stat3, amino acids 750 to 769. Stat4 antisera was raised against the C-terminal end of murine Stat4, amino acids 730 to 749. Stat6 antisera was raised against the C-terminal end of human Stat6, amino acids 828 to 847. Stat5 antibody" was the generous gift of Dr Hiroshi Wakao (DNAX Research Institute, Palo Alto, CA).
EMSA. Cells ( 2 1 Ob) in suspension were incubated in 1 mL PBS with or without cytokine at 37°C. Adherent cells (H-35 and HepG2) were grown in IO-cm plastic tissue culture dishes, incubated with cytokine in medium or PBS, washed, and harvested by scraping with a rubber policeman. Whole cell, cytoplasmic, and nuclear extracts were prepared and EMSAs were performed on 4% native polyacryamide gels as described.'".'' Tritiated-thymidine incorporation assay. Cells (1 @'/microtiter well) were incubated in triplicate in RPMI-1640 media containing 10% fetal bovine serum with or without G-CSF (Neupogen) or WEHI-3B-conditioned media as a source of murine 1L-3. Wells were pulsed with 0.5 pCi of ['HI-thymidine 18 hours before harvesting on day 3 onto glass fiber filters. The filters were counted by liquid scintillation and incorporation was measured as counts per minute.
RESULTS
G-CSF stimulated a DNA-binding protein that migrated with mobility similar
to SIF-A in human myeloid cells. EMSA of whole-cell extracts of hepatoma cells H-35 and HepG2 stimulated with IL-6 showed three protein complexes that bound the radiolabeled hSIE duplex oligonucleotide (m67)" that have previously been designated SIF-A, SIF-B, and SIF-C'" (Fig IA) . Stimulation of freshly isolated human neutrophils with G-CSF activated a DNA-binding protein that shifted hSIE on EMSA, forming a complex that migrated with mobility similar to SIF-A (Fig l) , hereafter designated G-SIF-A. Stimulation of neutrophils and hepatoma cells with IFN-y gave a characteristic SIF-C protein ~omplex.'~~'" Kinetic studies showed that G-SIF-A activation in neutrophils peaked within 15 to 30 minutes and decreased thereafter. returning to baseline by 4 hours (Fig 1B) . G-SIF-A activation was detected at concentrations of G-CSF as low as 1 ng/mL and peaked at 30 ng/mL, which is well within the physiologic concentration range" (Fig IC) . In contrast to G-CSF, GM-CSF stimulation for up to 3 hours did not activate G-SIF-A in neutrophils (Fig ID) . Analysis of nuclear and cytosolic extracts from G-CSF-stimulated neutrophils showed nuclear localization of G-SIF-A within 1 minute, with greater activity within the nucleus than cytoplasm at 30 minutes (Fig 1E) . Similar to neutrophils, G-CSF, but not GM-CSF, activated G-SIF-A in both normal BMMC and purified CD34' bone marrow cells (Fig 2A) . The kinetics of activation of G-SIF-A in bone marrow cells were similar to those in neutrophils (Fig 2B) .
G-SIF-A contains U distinct STAT-like protein. Two STAT proteins, Statl and Stat3, are known to bind hSIE.'4"7 Recent studies have indicated that the IL-6-stimulated SIF-A protein complex is composed of a Stat3 homodimer; the SIF-C complex is a Statl homodimer; and the SIF-B complex is a heterodimer of Statl and Stat3.'".3" Four additional STAT proteins have been cloned, including Stat2 (ISGF-3 p1 13)." Stat4,".lR Stat5 (MGF),'y.2',22 and Stat6 (IL4-Stat)."' We examined whether G-SIF-A is capable of binding to representative duplex oligonucleotides used to purify these other STAT proteins ( Table 1) . As shown in Fig 3A, G-SIF-A did not shift the GBP GAS,'4 ISRE,.3' IRF-I GAS,IX PRE, an element within the bovine casein promoter,'" or an element within the Fc y receptor I promoter.'" In addition, among these duplex oligonucleotides, only the hSIE could compete with radiolabeled hSIE for binding to G-SIF-A (Fig 3B) . In separate experiments performed under identical EMSA conditions, we showed that each duplex oligonucleotide listed in Table l was bound and shifted by its appropriate STAT protein(s) (data not shown). These results suggested that G-SIF-A most closely resembles Stat3, sharing similar electrophoretic mobility and binding element specificity.
To determine if G-SIF-A was distinct from Stat3, we ex- Whole cell extracts were prepared and analyzed by EMSA using radiolabeled hSlE duplex oligonucleotide. In (B), neutrophils were stimulated with G-CSF (1.000 nglmL1 for the times indicated before whole-cell extraction and EMSA using radiolabeled hSlE duplex oligonucleotide. In (C), neutrophils were stimulated for 15 minutes at the concentration of G-CSF indicated before whole-cell extraction and EMSA with radiolabeled hSIE. In (D), neutrophils were stimulated with G-CSF (100 nglmL) or GM-CSF (100 n g l mL) for the times indicated before whole-cell extraction and EMSA with radiolabeled hSIE. In (El, neutrophils were stimulated with G-CSF (100 nglmL) for the times indicated before extraction of cytoplasmic proteins followed by nuclear extraction. EMSA was performed on each set of extracts using radiolabeled hSIE. (Fig 4A) . However, the addition of up to 3 pg of this antibody failed to affect either the mobility or the formation of the G-SIF-A band in neutrophils, BMMC, and CD34' cells (Fig 4A and B) . The addition of polyclonal antibodies against Statl, Stat2, Stat4, StatS, and Stat6 each in an amount sufficient to supershift its respective Stat protein failed to supershift G-SIF-A or affect its formation (data not shown). These results suggested that G-SIF-A in normal human myeloid cells contains a STAT-like protein that is immunologically distinct from Stat3, as well as Statl, 2, 4, 5, and 6.
In contrast to the results using extracts from normal human myeloid cells, the G-SIF-A band formed by extracts from G-CSF-stimulated AML-193 cells (human acute myeloid leukemic cell line) and 32Dc13 cells (G- 
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DISCUSSION
G-CSF activated a DNA binding protein in human neutrophils, bone marrow cells, and G-CSF-responsive murine cell lines that bound hSIE duplex oligonucleotide, forming Cells were incubated in PBS alone (0) or PBS containing G-CSF (1.000 ng/mL; G), GM-CSF (1.000 ng/mL; GM), or IFN-7 (1.000 UlmL; I) for 15 minutes before whole cell extraction and EMSA using radiolabeled hSIE. Whole-cell extracts of HepG2 cells (Hep) stimulated with IL-6 G-SIF-A (1.000 U/mL) were incubated with radiolabeled hSlE and electrophoresed in lane 1. In (B), BMMC were exposed t o G-CSF (100 nglmL) for the times indicated before whole-cell extraction and EMSA using radiolabeled hSIE. 
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was also observed in 32Dc13 cells. The composition of this complex remains to be determined; of note, however, its formation and mobility appeared to be unaffected by antiStat3 antisera. cytometry analysis using affinity-purified G-CSFR anti-(l00 nglmLfor 15 minutes) and radiolabeled duplex oligonucleotides 1 through 6 ( Table 1) and were analyzed by EMSA. In (B), the indito G-CSF, whereas B-26 and the parental cell line did not 100-fold excess to binding reactions containing wholetell extracts of proliferate at all (Fig 5B) . Whole-cell extracts were prepared G-CSF-stimulated neutrophils plus radiolabeled hSlE before EMSA. a protein complex that migrated on EMSA with mobility similar to SIF-A (G-SIF-A). G-SIF-A activation in human neutrophils was detectable at a concentration of G-CSF as low as 1 ng/mL and occurred within 1 minute. Stimulation was maximal at 30 ng/mL and at 15 to 30 minutes. G-SIF-A translocated to the nucleus within 1 minute, with more activity residing in the nucleus than the cytoplasm by 30 minutes. G-SIF-A did not shift duplex oligonucleotides used to characterize Stat I , 2,4,5, or 6; nor could these oligonucleotides compete for hSlE binding. In addition, G-SIF-A in human neutrophils and bone marrow cells did not supershift with antisera directed against Stat3 or other members of the STAT protein family. These results indicated that G-SIF-A is composed of a distinct STAT-like protein present in normal myeloid cells. Receptor mapping studies showed that C-SIF-A activation did not correlate with G-CSF-induced proliferation and that maximal G-SIF-A activation required the Cterminal cytosolic half of the G-CSFR. Whereas G-SIF-A was composed of a DNA-binding factor distinct from Stat 1 -6 in normal human myeloid cells, a portion of the hSIE/G-SIF-A complexes in the human leukemia cell line, AML-193, and in G-CSF-responsive murine cell lines contained Stat3 or an antigenically related protein.
The unique hSIE-binding factor activated in G-CSF-stimulated normal human myeloid cells, tentatively designated StatG, appears to be distinct from the six STAT proteins that have been characterized thus far.12-24 All six STAT proteins, as well as StatG, bind to DNA elements 20 to 30 nucleotides long containing an 8-to IO-nucleotide core motif starting with TT and ending with AA. However, among the different DNA elements described, there is considerable variation in the nucleotide sequences within and surrounding this core motif that most likely contributes to their being preferential bound by individual STAT proteins. In addition to DNA binding preferences, there is considerable variability in the mobility of the different STAT proteins on EMSA. StatG resembles Stat3 in DNA binding preference and mobility on EMSA; however, because it does not supershift with anti-Stat3 antisera, StatG is distinct from Stat3. Furthermore, on the basis of DNA binding preference, mobility on EMSA, and lack of immunologic cross-reactivity, StatG also appears to be distinct from Statl, 2, 4, 5, and 6. StatG may represent a novel member of the STAT protein family or, alternatively, may arise through unique posttranscriptional or posttranslational modifications of one of the other STAT gene products. Further characterization and purification of neutrophil StatG is underway to distinguish between these alternatives.
Preliminary characterization, thus far, has shown that treatment of G-CSF-stimulated neutrophils with the tyrosine kinase inhibitor, genistein, as described,"' blocked StatG activation. In addition, treatment with pervanadate (vanadyl peroxide), which enhances tyrosine phosphorylation in whole cells," prolonged the activity of StatG (A. Chakraborty, unpublished data). These results suggest that, similar to other STAT proteins, tyrosine phosphorylation of StatG is essential for DNA binding. Investigations involving Statl, Stat3, and Stat6 suggest that they interact with the IFN-y receptor, members of the IL-6 receptor family, and the IL-4 receptor, respectively, through binding of a phosphorylated tyrosine site on the receptor via their SH2 or SH3:SH2 domains.2"~3x4" This interaction is proposed to cause juxtaposition of the STAT protein with a receptor-associated protein tyrosine kinase, resulting in phosphorylation of STAT on tyrosine and its subsequent di~nerization.~~.~' The cytosolic portion of the G-CSFR contains 4 tyrosine residues at amino acid positions 704, 729, 744, and 764, corresponding to cytosolic amino acid positions 73, 98, 113, and 133, respectively4.' (Fig 5A) . BAF/ B03 cells expressing truncated receptor mutants HGR-26 and HGR-57, which do not contain a tyrosine within their cytosolic domain, did not show G-SIF-A activation in response to G-CSF. In addition, in cells expressing HGR-96, which contains only one tyrosine (Y704) in its cytosolic domain, only modest activation of G-SIF-A was observed. These results suggest that Stat3 and the hSIE/protein complex lacking Stat3 (tentatively designated StatG) may be recruited preferentially to one of the distal 3 tyrosine sites (Y98, Y I 13, and Y 133) within the cytosolic domain of the full-length receptor. This region of the G-CSFR cytosolic domain has been found to be critical for the induction of differentiation by G-CSF?' The finding that Stat3 and possibly StatG are maximally activated by full-length receptor, together with the fact that their activation is not required for proliferation, suggests that they may be specifically involved in the signaling pathway directing myeloid differentiation by G-CSF. Our findings in AML-193 suggest that StatG is activated in this cell line in response to G-CSF, in addition to Stat3, as previously rep~rted.'~ Stat3 was not activated in normal human myeloid cells, including CD34+ bone marrow cells, which suggests that its activation by G-CSF in human leukemic cells is aberrant. This finding raises the possibility that activation of alternative transcription factors by G-CSF in some leukemic cells may contribute to their failure to activate the normal differentiation program in response to this cytokine. The aberrant activation of Stat3 in some AML cells may be the result of its being abnormally expressed in these cells or may be secondary to its recruitment and activation by an abnormal G-CSFR isoform. Each of these possibilities is being actively investigated.
In contrast to G-CSF, GM-CSF did not activate SIF-A in normal human myeloid cells. Many studies have showed that, although there is some overlap, G-CSF and GM-CSF each have distinct biologic effects. Most notable is the ability of G-CSF to specifically drive the terminal differentiation of committed myeloid precursors to Cloning of their receptors has given substantial insight into their distinct biologic functions by showing that, although they both belong to the hematopoietidcytokine receptor family, each belongs to a distinct subset of this family!14 We have previously delineated overlap in the signaling pathway for G-CSF and GM-CSF. Both were shown to activate Lyn and Syk, although Syk activation by G-CSF was more dramatic than that by GM-CSF." Our finding of G-SIF-A activation by G-CSF but not by GM-CSF shows a clear divergence in signaling and transcriptional pathways for these two hematopoietins in normal cells. Recent studies in murine myeloid cells showing that GM-CSF, along with IL-3 and IL-5, activates Stat5" support the conclusion that G-CSF and GM-CSF signaling diverge at the level of STAT protein activation.
The unique ability of G-CSF to drive terminal neutrophilic granulocyte differentiation together with our findings that G-SIF-A activation does not correlate with proliferation, is specific for G-CSF versus GM-CSF, and maps to the differentiation-specific region of the G-CSFR implicate a critical role for G-SIF-A in the neutrophilic differentiation program.
